Prelude Capital Management’s Cyclerion Therapeutics CYCN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-4,627
| Closed | -$80K | – | 1228 |
|
|
2022
Q3 | $80K | Sell |
4,627
-1,683
| -27% | -$29.1K | ﹤0.01% | 1156 |
|
|
2022
Q2 | $69K | Buy |
6,310
+1,297
| +26% | +$14.2K | ﹤0.01% | 1244 |
|
|
2022
Q1 | $111K | Buy |
5,013
+1,134
| +29% | +$25.1K | ﹤0.01% | 1101 |
|
|
2021
Q4 | $133K | Buy |
3,879
+1,752
| +82% | +$60.1K | ﹤0.01% | 1300 |
|
|
2021
Q3 | $131K | Sell |
2,127
-378
| -15% | -$23.3K | ﹤0.01% | 1111 |
|
|
2021
Q2 | $195K | Buy |
+2,505
| New | +$195K | 0.01% | 1118 |
|
|
2019
Q4 | – | Sell |
-50
| Closed | -$12K | – | 1476 |
|
|
2019
Q3 | $12K | Buy |
+50
| New | +$12K | ﹤0.01% | 996 |
|